Incanthera plc
Research Incanthera plc (INC.AQ) on Bullrun: market cap GBP 510.37M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerINC.AQ
- ExchangeAQSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyGBp
- Market capGBP 510.37M
- Financial periodFY2024
- RevenueGBP 0
- Net income-GBP 1.55M
- Free cash flow-GBP 838.00K
Valuation Snapshot
latest market cap is GBP 510.37M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | GBP 0 | -GBP 1.55M | -GBP 838.00K | n/a | -0.02 | GBP 61.00K | GBP 0 | -GBP 565.00K |
| FY2023 | GBP 0 | -GBP 1.37M | -GBP 452.00K | n/a | -0.02 | GBP 3.00K | GBP 131.00K | -GBP 214.00K |
| FY2022 | GBP 0 | -GBP 1.01M | -GBP 662.00K | n/a | -0.01 | GBP 295.00K | GBP 0 | GBP 832.00K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | GBP 510.37M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBP.
About Incanthera plc
Incanthera plc engages in the discovery and development of technologies in dermatology and oncology in the United Kingdom, Switzerland, and the United States. The company develops skincare products under the Skin + CELL brand name. It is also involved in skin formulation and delivery technologies; and develops pharmaceutical products. Incanthera plc was founded in 2010 and is headquartered in Manchester, the United Kingdom.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Incanthera plc's market cap?
Incanthera plc's market capitalization is GBP 510.37M.
What does Incanthera plc do?
Incanthera plc engages in the discovery and development of technologies in dermatology and oncology in the United Kingdom, Switzerland, and the United States. The company develops skincare products under the Skin + CELL brand name. It is also involved in skin formulation and delivery technologies; and develops pharmaceutical products. Incanthera plc was founded in 2010 and is headquartered in Manchester, the United Kingdom.